Earnings History Data for VBI Vaccines (VBIV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

VBI Vaccines

VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-05-2024	AH	VBIV	VBI Vaccines	18.00	-0.55	-0.53	0.00	VBI Vaccines GAAP EPS of -$0.73 misses by $0.20, revenue of $1.21M misses by $1.64M [5/15/2024 5:06 PM]	0.6501	-0.01 (-1.05%)	0.65	-0.01 (-1.07%)	0.45 - 3.47	127,211	110,000	8,063
VBI Vaccines GAAP EPS of -$0.73 misses by $0.20, revenue of $1.21M misses by $1.64M [5/15/2024 5:06 PM]
14-11-2023	AH	VBIV	VBI Vaccines	14.00	-0.38	-0.14	0.00	VBI Vaccines Non-GAAP EPS of -$0.38, revenue of $6.62M misses by $6.63M [11/14/2023 4:43 PM]	0.6350	-0.02 (-2.31%)	0.68	0.03 (4.62%)	0.45 - 21.00	72,661	160,000	7,427
VBI Vaccines Non-GAAP EPS of -$0.38, revenue of $6.62M misses by $6.63M [11/14/2023 4:43 PM]
10-11-2022	PM	VBIV	VBI Vaccines	167.00	-0.09	-0.08	0.00	VBI Vaccines GAAP EPS of -$0.10 misses by $0.02, revenue of $0.32M misses by $0.97M [11/10/2022 8:45 AM]	0.5930	-0.01 (-2.05%)	0.61	0.0 (0.31%)	0.58 - 3.41	1,135,051	570,000	57,107
VBI Vaccines GAAP EPS of -$0.10 misses by $0.02, revenue of $0.32M misses by $0.97M [11/10/2022 8:45 AM] VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-10-22 08:00AM]
07-03-2022	PM	VBIV	VBI Vaccines	353.00	-0.07	-0.07	0.00	VBI Vaccines GAAP EPS of $0.27 beats by $0.54, revenue of $0.63M misses by $0.17M [3/7/2022 8:13 AM]	1.42	0.11 (8.40%)	1.31	0.0 (0.00%)	1.21 - 4.31	1,212,085	1,770,000	2,463
VBI Vaccines GAAP EPS of $0.27 beats by $0.54, revenue of $0.63M misses by $0.17M [3/7/2022 8:13 AM] VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2021, Provides Corporate Update and Outlook for 2022 [Mar-07-22 08:00AM] QualTek Names New Independent Board Appointees to its Board of Directors [Mar-07-22 07:57AM] VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates [Mar-07-22 09:15AM]
10-05-2021	PM	VBIV	Vbi Vaccines, Inc.	689.00	-0.07	-0.07	0.00	VBI Vaccines EPS misses by $0.01, misses on revenue [5/10/2021 8:15 AM]	2.65	-0.13 (-4.68%)	2.78	0.0 (0.00%)	1.34 - 6.93	2,666,114	3,240,000	24,954
VBI Vaccines EPS misses by $0.01, misses on revenue [5/10/2021 8:15 AM] VBI Vaccines Announces First Quarter 2021 Financial Results and Provides Corporate Update [May-10-21 08:00AM] VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates [May-10-21 09:15AM]
02-11-2020	PM	VBIV	VBI Vaccines, Inc.	543.32	-0.06	-0.05	-0.15	VBI Vaccines reports Q3 results [11/2/2020 8:05 AM]	2.46	-0.07 (-2.77%)	2.46	0.0 (0.00%)	0.53 - 6.93	4,479,523	4,726,750	17,509

06-05-2020	PM	VBIV	VBI Vaccines, Inc.	283.70	-0.05	-0.06	-0.15	VBI Vaccines EPS beats by $0.02, misses on revenue [5/6/2020 8:05 AM]	1.24	0.01 (0.81%)	1.26	0.02 (1.61%)	0.47 - 2.10	4,400,766	12,205,526	44,770